Related Experiment Video
Updated: Apr 18, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Aspergillus flavus endocarditis of the native mitral valve in a bone marrow transplant patient
Tolga Demir1, Mehmet Umit Ergenoglu2, Abdurrahman Ekinci2
1Department of Cardiovascular Surgery, Beylikduzu Kolan Hospital, Istanbul, Turkey.
Background:
Infective endocarditis due to Aspergillus species is an uncommon infection with a high mortality rate. It mostly occurs after the implantation of prosthetic heart valves. Parenteral nutrition, immunosuppression, broad-spectrum antibiotic regimens, and illegal intravenous drug use are the risk factors for developing infection.
Case Report:
We report a case of Aspergillus flavus native mitral valve endocarditis in a patient who had allogeneic stem cell transplantation in the past due to myelodysplastic syndrome.
Conclusions:
Although it is rare and there is limited experience available with the diagnosis and treatment, early recognition and therapeutic intervention with systemic antifungal therapy and aggressive surgical intervention are critical to prevent further complications that may eventually lead to death. In addition, better novel diagnostic tools are needed to facilitate more accurate identification of patients with invasive Aspergillus and to permit earlier initiation of antifungal treatment.
Insights
Aspergillus flavus endocarditis is a rare but deadly infection, often seen after heart valve surgery. Early antifungal treatment and surgery are crucial for survival.
Area of Science:
- Infectious Diseases
- Cardiology
- Mycology
Background:
- Infective endocarditis caused by Aspergillus species is rare but has a high mortality rate.
- Prosthetic heart valves, parenteral nutrition, immunosuppression, and intravenous drug use are associated risk factors.
- Aspergillus endocarditis is an opportunistic infection often seen in immunocompromised individuals.
Observation:
- This case report details Aspergillus flavus native mitral valve endocarditis in a patient with a history of allogeneic stem cell transplantation for myelodysplastic syndrome.
Findings:
- The case highlights a unique presentation of invasive aspergillosis in an immunocompromised patient.
- Successful management required a combination of systemic antifungal therapy and aggressive surgical intervention.
Implications:
- Early diagnosis and prompt, multidisciplinary treatment are vital for improving outcomes in invasive Aspergillus endocarditis.
- Development of novel diagnostic tools is needed for earlier identification and treatment initiation, potentially reducing mortality.
More Related Videos
08:01Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
10:31Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Endocarditis I: Introduction
Mitral Stenosis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management